rs386833814
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_003982.4(SLC7A7):c.371T>C(p.Leu124Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003982.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC7A7 | NM_003982.4 | c.371T>C | p.Leu124Pro | missense_variant | 2/10 | ENST00000674313.1 | |
SLC7A7 | NM_001126105.3 | c.371T>C | p.Leu124Pro | missense_variant | 3/11 | ||
SLC7A7 | NM_001126106.4 | c.371T>C | p.Leu124Pro | missense_variant | 3/11 | ||
SLC7A7 | XM_011537299.2 | c.371T>C | p.Leu124Pro | missense_variant | 2/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC7A7 | ENST00000674313.1 | c.371T>C | p.Leu124Pro | missense_variant | 2/10 | NM_003982.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249920Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135230
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461888Hom.: 0 Cov.: 70 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome ? AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
Lysinuric protein intolerance Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Feb 24, 2022 | ClinVar contains an entry for this variant (Variation ID: 56366). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This missense change has been observed in individual(s) with lysinuric protein intolerance (PMID: 18716612). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs386833814, gnomAD 0.008%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 124 of the SLC7A7 protein (p.Leu124Pro). - |
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 25, 2021 | Variant summary: SLC7A7 c.371T>C (p.Leu124Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249920 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.371T>C has been reported in the literature in at-least three individuals affected with Lysinuric Protein Intolerance (example Sperandeo_2008, Font-Llitjos_2009) and has been subsequently cited by others (example, Zhang_2017, Martinelli_2020). At-least two of these three affected individuals were reportedly genotyped comprehensively and the variant segregated with disease within this single family as biparental recessive inheritance (Font-Llitjos_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, until additional clinical reports in patients and /or supportive functional studies are reported, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at